BlackRock’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $18.3M | Sell |
|
|||||
|
2025
Q2 | $12.6M | Buy |
|
|||||
|
2025
Q1 | $7.97M | Sell |
|
|||||
|
2024
Q4 | $12M | Buy |
|
|||||
|
2024
Q3 | $10.4M | Buy |
|
|||||
|
2024
Q2 | $11.3M | Sell |
|
|||||
|
2024
Q1 | $17.7M | Sell |
|
|||||
|
2023
Q4 | $22.3M | Buy |
|
|||||
|
2023
Q3 | $15.7M | Sell |
|
|||||
|
2023
Q2 | $22.3M | Sell |
|
|||||
|
2023
Q1 | $103M | Sell |
|
|||||
|
2022
Q4 | $140M | Buy |
|
|||||
|
2022
Q3 | $124M | Buy |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $23.9M | Buy |
|
|||||
|
2021
Q4 | $33.9M | Buy |
|
|||||
|
2021
Q3 | $19.6M | Buy |
|
|||||
|
2021
Q2 | $19.7M | Buy |
|
|||||
|
2021
Q1 | $29.1M | Buy |
|
|||||
|
2020
Q4 | $14.1M | Buy |
|